Redwire Corporation vs Zoetis Inc — how do they compare? Redwire Corporation trades at $9.55 (market cap $2.44B), while Zoetis Inc trades at $74.76 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 12.4× Redwire Corporation's market cap, and Zoetis Inc pays a 2.9% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Redwire Corporation for 18 Days and Zoetis Inc for 70 Days on average.
| RDW | ZTS | |
|---|---|---|
Market Cap | $2.44B | $30.20B |
Volume | 11,053,212 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $25.90 | $147.53 |
52-Week Low | $5.06 | $69.09 |
Typical Hold Time | 18 Days | 70 Days |
Enterprise Value | $1.97B | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
RDW trades at $9.58, down 6.45% today, with technical indicators showing bearish momentum despite oversold RSI readings near 27. The company reported significant losses with a -57.26% net income margin and negative cash flow from operations, though revenue grew to $335M in 2025. Recent Space Force contract wins and partnerships highlight growth potential in defense and space infrastructure markets.
While analyst consensus remains bullish with an 80% buy rating and $14.88 price target, RDW faces substantial execution risks from persistent losses and dependence on SpaceX's Starship success. The stock offers high-risk exposure to the growing space economy but requires careful monitoring of profitability improvements and contract execution.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →